These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 19202569)
1. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia. Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733 [No Abstract] [Full Text] [Related]
3. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related]
4. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion. Czyz A; Lewandowski K; Kroll R; Komarnicki M Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746 [TBL] [Abstract][Full Text] [Related]
5. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Ottmann OG; Pfeifer H Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223 [TBL] [Abstract][Full Text] [Related]
6. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy]. Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652 [TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Teng CL; Yu JT; Chen HC; Hwang WL Ann Hematol; 2013 Aug; 92(8):1137-9. PubMed ID: 23307602 [No Abstract] [Full Text] [Related]
8. Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation. Conchon M; Sanabani SS; Bendit I; Serpa M; Filho UA; de Barros Ferreira P; Novaes MM; Saboya R; Llacer-Dorliac PE; Dulley FL Bone Marrow Transplant; 2010 Jun; 45(6):1125-6. PubMed ID: 19855440 [No Abstract] [Full Text] [Related]
9. Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Gruber F; Mustjoki S; Porkka K Br J Haematol; 2009 Jun; 145(5):581-97. PubMed ID: 19388927 [TBL] [Abstract][Full Text] [Related]
10. Dasatinib after allogeneic stem cell transplantation in a child with Philadelphia chromosome positive acute lymphoblastic leukemia. de Castro CG; Gregianin LJ; Meneses CF; Brunetto AL Pediatr Blood Cancer; 2009 Dec; 53(6):1161. PubMed ID: 19621456 [No Abstract] [Full Text] [Related]
11. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Watanabe A; Chansu S; Ogawa A; Asami K; Imamura M Pediatr Int; 2013 Jun; 55(3):e56-8. PubMed ID: 23782380 [TBL] [Abstract][Full Text] [Related]
14. Management of Bcr-Abl-positive leukemias with dasatinib. Hochhaus A Expert Rev Anticancer Ther; 2007 Nov; 7(11):1529-36. PubMed ID: 18020922 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F; Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726 [TBL] [Abstract][Full Text] [Related]
16. [Second-generation tyrosine kinase inhibitors combined with allogeneic hematopoietic stem cell transplant for Philadelphia chromosome positive leukemia]. Yu X; Li C; Wu X; Ye L; Liu H; Ma C; Ma J; Gu C; Wu D Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):129-33. PubMed ID: 24606654 [TBL] [Abstract][Full Text] [Related]
17. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome. Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058 [TBL] [Abstract][Full Text] [Related]
18. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia? DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665 [TBL] [Abstract][Full Text] [Related]
19. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Matsue K; Tabayashi T; Yamada K; Takeuchi M Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia. Akahoshi Y; Nishiwaki S; Mizuta S; Ohashi K; Uchida N; Tanaka M; Fukuda T; Ozawa Y; Takahashi S; Onizuka M; Shiratori S; Nakamae H; Kanda Y; Ichinohe T; Atsuta Y; Kako S; Cancer Sci; 2019 Oct; 110(10):3255-3266. PubMed ID: 31402561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]